Upstart stock has been volatile in 2025, and it's down 23.5% year to date. As interest rates have slowly declined, the ...

Delcath Systems, Inc. , an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today provided preliminary revenue and financial results for the quarter ...